alexa Research And Development New Synbiotic Product And Its Clinical Effect | 21284
ISSN: 2329-8901

Journal of Probiotics & Health
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference and Exhibition on Probiotics, Functional & Baby Foods

Almagul Kushugulova, S Kozhakhmetov, S Saduakhasova, G Shakhabayeva, Zh Khasenbekova, I Tynybayeva, D Baiskhanova, A Kakimova, T Nurgozhin and Zh Zhumadilov
ScientificTracks Abstracts: J Prob Health
DOI: 10.4172/2329-8901.S1.015
Abstract
Introduction: Currently, the functional food is recognized as an alternative to pharmacotherapy. The objective of research is a synbiotic product ?NAR?, which includes probiotics and prebiotics. Probiotics are presented by cultures of Lactobacillus plantarum, Lactobacillus fermentum, Lactobacillus acidophilus, Bifidobacteriumlongum, Bifidobacteriumbifidum. The product is also enriched with fish collagen.The goal of this work is to investigate the clinical efficacy of a new synbiotic. Method: Double-blind, randomised, placebo-controlled trial, including 180 adult (age 30-89) with symptomes of metabolic syndrome whowere allocated to placebo or synbiotic group. We enrolled 90 adult in placebo group and 90 in synbiotic group. The two groups were similar for demographic and clinical characteristics. All patients signed a consent letter. The main criteria for inclusion were: Blood pressure: 130/90 mmHg; Raised fastingplasma glucose (FPG): >100 mg/dL (5.6 mmol/L), or previously diagnosed type 2 diabetes; Dyslipidemia: triglycerides (TG): =1.695 mmol/L and high-density lipoprotein cholesterol (HDL-C) =0.9 mmol/L (male), =1.0 mmol/L (female); Central obesity:waist:hip ratio >0.90 (male); >0.85 (female), or body mass index >30 kg/m2. All patients underwent clinical and laboratory evaluation, including completeblood tests, glucose test, glycosylated hemoglobin, total cholesterol + triglycerides, cholesterol, LDL, HDL plasma, immunogram, co-program. All patients were interviewed, the questionnaire included 200 questions related to diet, lifestyle andhealth. Synbiotic were used by patients in dose of 200 grams twice a day. The duration of applying the symbiotic were 90 days. Results: In the study group the percentage of colds were significantly lower than in placebo group, the majority of patients reported an improvement in abdominal discomfort, reduction in serum total cholesterol and low-density lipoprotein, weight loss of 8-9 percent in different age groups, stabilized frequency and consistency of stool (judging by the Bristol scale). Conclusion: As a result was exhibited the efficacy of a new synbiotic in adult with metabolic syndrome.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version